Who we are
An Italian company with direct control over development, production and international distribution.
Founded in 2012, based in Valenza (Alessandria), Alfakjn designs and manufactures medical devices in selected therapeutic areas, distributing them through local partners in 23 countries. Our structure is that of a short supply chain company: from product development and regulatory management to distributor support, everything remains within a controlled and measurable system.
This model is not a default choice. It is the answer to a precise question: how to build products that have a clear positioning, robust documentation and the continuity of supply that a distribution partner can guarantee to their market?
Development, production and support: a supply chain that remains short by choice
The Alfakjn model is built around the direct control of every phase relevant to the distributor:
- Proprietary development: Alfakjn formulations stem from internal research, in collaboration with Italian universities and specialised centres. The active patents (3 granted, 1 pending) are part of this journey.
- Italian production: All Alfakjn medical devices are manufactured in Italy, with in-house quality control and raw materials selected to high standards.
- Direct regulatory management: the company manages MDR compliance, EUDAMED registration and the necessary technical documentation for target markets in-house. This translates into faster response times and consistently up-to-date documentation for the distributor.
- Distributor support: technical materials, positioning adjustment, product reading support: Alfakjn supports its partners, it doesn't just supply the product lines.
14 years of international presence, built market by market
Since 2012, Alfakjn has developed a distribution network in 23 countries, with a presence concentrated in four macro-areas: Europe, the former Soviet region, MENAT and Asia.
The expansion model was not based on large centralised agreements, but on relationships built with local partners who know their own market: clinical dynamics, regulatory expectations and the referral channel (pharmacy, clinic, hospital, specialist distribution).
This mode has a direct advantage for those evaluating a partnership: Alfakjn has already gone through the adaptation process in different contexts, and can share materials, approaches and documentation already tested in similar markets.
Regulatory compliance: not a tick-box exercise, a competitive advantage
Operating in regulated markets with certified medical devices requires precise and continuous document management. Alfakjn internally manages compliance with the European MDR (Medical Device Regulation), EUDAMED registration and the 9 currently active regulatory and quality certifications.
For the distributor, this translates into three tangible benefits:
- Complete and up-to-date technical documentation: available for introduction into target markets, without waiting for updates from third parties.
- Compliance continuity over time: Alfakjn monitors regulatory changes and proactively updates the documentation.
- Non-EU markets support: experience in managing the regulatory equivalences required in MENAT, post-Soviet and Asian markets.
The 9 active certifications cover process quality, device safety and specific requirements for international markets.
Precise positioning in a crowded market
The medical devices market is polarised: on the one hand, large international players with broad portfolios and established sales structures; on the other, small niche businesses, often single-product and with operational vulnerabilities.
Alfakjn occupies an intermediate space. Structured enough to ensure production continuity, regulatory management and distributor support. Focused enough to carefully choose the therapeutic areas in which to enter, the markets in which to expand and the partners with whom to work.
"Unconventional Health Solutions is not just a tagline: it is the criterion by which we evaluate every new product. First we ask ourselves whether a clinical need is truly being adequately met by available solutions; then — and only then — do we consider how to develop something that is differentiating for the distributor and relevant for the professional.
